15+ years of Bringing the Industry together on a Common Platform

Navitas Life Sciences is the proud host of neutral platforms for Pharmacovigilance (PV) leaders facing similar challenges to network, debate, compare performance, and share ideas on how to tackle the latest hot issues (including balancing rising workload with resource constraints, managing divergent global regulatory requirements, implementing continuous benefit risk management, leveraging new tools and big data, and modernizing PV in the context of the seismic technology and industry shifts).

Our Network Communities Discuss Trends, Develop Insights, & Build Future Solutions

Be part of the only global PV network with exclusive access to:

  • Benchmark Information

    benchmark information

    Deliver benchmark information to compare and measure operational and organizational performance

  • PV Insights


    Provide access to the latest PV insights through webcasts, think tanks, white papers and community exchange

  • Secure Collaboration Tool


    Secure collaboration tool and resource hub with the latest documented insights

Future proof your PV system, engage with global peers and compare and improve your performance

Factors shaping PV

  • Understand internal and external factors shaping PV
  • Learn from peers on successes & pitfalls of innovative pilots
  • Build a best practice PV system and network - now & future

Neutral Platform for PV Leaders

  • A neutral platform / sounding board for PV leaders facing similar challenges to network, debate & share ideas
  • Be part of industry leading community groups to shape and develop the future of PV

PV Performance

  • Compare / measure your PV Performance against peers, Use data to identify priority improvement opportunities
  • Build future PV strategies to boost compliance, enhance performance and build the value of your PV function

Our Industry Networks Include

Latest News & Articles


Encouraging patient-centric innovation in pharma

Dr Ayaaz Hussain Khan, Global Head Generics, Navitas Life Sciences (a TAKE Solutions...


Barriers Preventing Clinical Trial Software Development

Back in August of 2011 in the Wall Street Journal, Marc Andressen, the...